Canada · Delayed Price · Currency is CAD Methanex Earnings Call Transcripts
Fiscal Year 2026
-
Q2 saw strong financial performance with adjusted EBITDA of $577M and net income of $300M, driven by higher methanol prices amid Middle East supply disruptions. The Titan plant in Trinidad was idled, and shipping costs rose sharply. Guidance for 2026 production remains at 9M tons.
-
Q1 2026 saw higher realized prices and EBITDA, with strong cash flow enabling debt repayment. Middle East supply disruptions have driven global methanol prices up, and Q2 earnings are expected to rise sharply if current pricing holds.
Fiscal Year 2025
-
Fourth quarter 2025 saw higher production but lower realized prices, resulting in lower Adjusted EBITDA and a net loss. Integration of new assets is progressing, with all free cash flow prioritized for debt repayment amid ongoing market volatility and supply risks.
-
Revised summary: The company is shifting from investment to impact, leveraging a stronger North American asset base and the OCI acquisition to drive free cash flow in a tight methanol market. Operational excellence, supply chain flexibility, and disciplined capital allocation support strong financials, while low carbon methanol growth positions it for future demand.
-
Q3 2025 saw higher adjusted EBITDA and strong production from newly integrated assets, despite lower realized prices. The company is focused on deleveraging, expects higher Q4 EBITDA, and continues to manage gas supply risks and integration synergies.
-
Q2 2025 saw lower adjusted EBITDA due to softer methanol prices, but integration of the OCI acquisition is progressing well, with new assets running at high rates. Guidance points to higher Q3 EBITDA and a focus on deleveraging, while market demand remains robust, especially in China.
-
Q1 2025 delivered higher adjusted EBITDA and net income on strong methanol pricing and sales, with tight global supply conditions easing into Q2. The OCI acquisition is on track for Q2 close, with all free cash flow prioritized for deleveraging and a cautious outlook amid lower forecasted prices and ongoing gas supply risks.
Fiscal Year 2024
-
Record safety and strong financials in 2024, with Q4 adjusted EBITDA up on higher prices and sales. OCI acquisition on track for Q2 2025 close, with focus on deleveraging and integration. Tight methanol markets and supply constraints support robust pricing into 2025.
-
Q3 2024 delivered higher adjusted EBITDA and net income, driven by improved pricing, insurance recovery, and gas sales, despite lower production from gas constraints. The company secured key gas contracts, optimized operations, and remains focused on deleveraging post-OCI transaction.
-
A $2.05 billion acquisition will add over 20% to North American methanol capacity, diversify into ammonia and low-carbon fuels, and is expected to deliver $30 million in annual synergies. The deal is structured for financial flexibility, with closing targeted for H1 2025.
-
Q2 2024 saw higher realized prices and improved adjusted EBITDA, driven by strong demand and the G3 plant restart. Production was impacted by gas constraints in several regions, but full-year volume guidance is maintained, with G3 expected to boost future earnings.